Low-Dose Clozapine-Induced Agranulocytosis in Patients with Movement Disorders-Retrospective Study from India.
作者信息
Choudhury Supriyo, Banerjee Sattwika, Chatterjee Koustav, Basu Purba, Baker Mark R, Kumar Hrishikesh
机构信息
Department of Neurology, Institute of Neurosciences Kolkata, West Bengal, India.
Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
出版信息
Ann Indian Acad Neurol. 2021 Sep-Oct;24(5):831-832. doi: 10.4103/aian.AIAN_522_20. Epub 2020 Aug 28.
Abstract
摘要
相似文献
1
Low-Dose Clozapine-Induced Agranulocytosis in Patients with Movement Disorders-Retrospective Study from India.低剂量氯氮平诱发运动障碍患者粒细胞缺乏症——来自印度的回顾性研究
Ann Indian Acad Neurol. 2021 Sep-Oct;24(5):831-832. doi: 10.4103/aian.AIAN_522_20. Epub 2020 Aug 28.
2
Late onset clozapine induced agranulocytosis.迟发性氯氮平所致粒细胞缺乏症。
Indian J Psychol Med. 2014 Oct;36(4):425-7. doi: 10.4103/0253-7176.140738.
3
Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.1982-2007 年芬兰氯氮平所致粒细胞缺乏症：仍需对患者进行长期监测。
J Clin Psychiatry. 2012 Jun;73(6):837-42. doi: 10.4088/JCP.11m07244. Epub 2012 Mar 6.
4
Life-threatening thrombocytosis following GCSF treatment in a case of clozapine-induced agranulocytosis.粒细胞缺乏症患者接受 G-CSF 治疗后发生危及生命的血小板增多症。
Gen Hosp Psychiatry. 2012 May-Jun;34(3):320.e1-2. doi: 10.1016/j.genhosppsych.2011.09.011. Epub 2011 Oct 21.
5
Clozapine treatment after agranulocytosis induced by classic neuroleptics.经典抗精神病药物引起粒细胞缺乏症后的氯氮平治疗。
J Clin Psychopharmacol. 1994 Feb;14(1):71-3.
6
Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.服用氯氮平的中国患者中的中性粒细胞减少症和粒细胞缺乏症
East Asian Arch Psychiatry. 2015 Dec;25(4):164-7.
7
No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis.人类白细胞抗原（HLA）系统在氯氮平所致粒细胞缺乏症中无直接临床关联。
Drug Saf. 1992;7 Suppl 1:3-6. doi: 10.2165/00002018-199200071-00004.
8
Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.氯氮平和奥氮平对中性粒细胞动力学的影响：对药物性粒细胞缺乏症的意义。
Chem Res Toxicol. 2014 Jul 21;27(7):1104-8. doi: 10.1021/tx500183x. Epub 2014 Jul 8.
9
Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.英国和爱尔兰接受氯氮平治疗患者的中性粒细胞减少症和粒细胞缺乏症。
Br J Psychiatry. 1996 Oct;169(4):483-8. doi: 10.1192/bjp.169.4.483.
10
Major histocompatibility complex associations with clozapine-induced agranulocytosis. The USA experience.主要组织相容性复合体与氯氮平所致粒细胞缺乏症的关联。美国的经验。
Drug Saf. 1992;7 Suppl 1:7-9. doi: 10.2165/00002018-199200071-00005.
引用本文的文献
1
Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016.氯氮平相关的药物不良反应：1993 年至 2016 年期间 AMSP 项目的药物监测数据。
在 38349 名精神科住院患者中
J Neural Transm (Vienna). 2024 Sep;131(9):1117-1134. doi: 10.1007/s00702-024-02818-7. Epub 2024 Aug 13.
本文引用的文献
1
Meta-analysis examining the epidemiology of clozapine-associated neutropenia.元分析检查氯氮平相关中性粒细胞减少症的流行病学。
Acta Psychiatr Scand. 2018 Aug;138(2):101-109. doi: 10.1111/acps.12898. Epub 2018 May 21.
2
Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.氯氮平引起粒细胞缺乏症的机制：研究现状及对药物开发的启示。
CNS Drugs. 1997 Feb;7(2):139-58. doi: 10.2165/00023210-199707020-00005.
3
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.氯氮平与其他第二代抗精神病药物治疗难治性精神分裂症效果的随机对照试验
Schizophr Bull. 2006 Oct;32(4):715-23. doi: 10.1093/schbul/sbj067. Epub 2006 Mar 15.
4
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.氯氮平改善帕金森病的运动障碍：一项双盲、安慰剂对照研究。
Neurology. 2004 Feb 10;62(3):381-8. doi: 10.1212/01.wnl.0000110317.52453.6c.
5
Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.氯氮平所致粒细胞缺乏症。美国的发病率及危险因素。
N Engl J Med. 1993 Jul 15;329(3):162-7. doi: 10.1056/NEJM199307153290303.
6
Clozapine in the treatment of psychosis in Parkinson's disease.氯氮平治疗帕金森病所致精神病
Neurology. 1989 Sep;39(9):1219-21. doi: 10.1212/wnl.39.9.1219.
Zotero 插件